Extending the dosing range for simvastatin: The efficacy and safety of Simvastatin 80 mg/d

被引:0
|
作者
Ose, L [1 ]
Corsetti, LA [1 ]
Tate, AC [1 ]
Shahane, A [1 ]
Mitchel, YB [1 ]
机构
[1] MERCK RES LABS,RAHWAY,NJ
关键词
D O I
10.1016/S0021-9150(97)88706-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:131 / 131
页数:1
相关论文
共 50 条
  • [21] SAFETY, TOLERABILITY, AND EFFICACY OF SIMVASTATIN AND FENOFIBRATE - A MULTICENTER STUDY
    ZIEGLER, O
    DROUIN, P
    CARDIOLOGY, 1990, 77 : 50 - 57
  • [22] Efficacy and safety of oral simvastatin in the treatment of patients with vitiligo
    Zhang, Shiyu
    Zdravkovic, Tanja Prunk
    Wang, Tao
    Liu, Yuehua
    Jin, Hongzhong
    JOURNAL OF INVESTIGATIVE MEDICINE, 2021, 69 (02) : 393 - 396
  • [23] Efficacy and safety of Simvastatin for high-risk hypercholesterolemia
    Mölgaard, J
    Wärjerstam-Elf, S
    Olsson, AG
    AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (07): : 1043 - 1048
  • [24] Translated Paper: Comparison of efficacy and safety of atorvastatin (10 mg) and simvastatin (10 mg) at six weeks.
    Insull, W
    Kafonek, S
    Goldner, D
    PERFUSION, 2001, 14 (06): : 244 - 250
  • [25] Safety and efficacy of enalapril and simvastatin in dialysis patients.
    Collins, JF
    Robson, R
    MacMahon, S
    KIDNEY INTERNATIONAL, 1996, 50 (04) : 1410 - 1410
  • [26] COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN - REPLY
    SWEANY, AE
    SHAPIRO, DR
    TATE, AC
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (09): : 723 - 724
  • [27] LONG-TERM SAFETY AND EFFICACY PROFILE OF SIMVASTATIN
    BOCCUZZI, SJ
    BOCANEGRA, TS
    WALKER, JF
    SHAPIRO, DR
    KEEGAN, ME
    AMERICAN JOURNAL OF CARDIOLOGY, 1991, 68 (11): : 1127 - 1131
  • [28] Simvastatin in management of patients with primary hypercholesterolemia: Tolerability and efficacy of daily doses 10-80 mg
    Susekov, AV
    Solovyeva, EY
    Rozhkova, TA
    Kotova, LA
    Akhmedova, ZA
    Kukharchuk, VV
    KARDIOLOGIYA, 2002, 42 (01) : 33 - 36
  • [29] THE EFFICACY AND SAFETY OF PRAVASTATIN AND SIMVASTATIN IN PATIENTS WITH PRIMARY HYPERCHOLESTEROLEMIA
    VOLPE, R
    ARCA, M
    GINNETTI, MG
    ANTONINI, R
    RICCI, G
    URBINATI, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1992, 51 (03): : 422 - 430
  • [30] COMPARISON OF THE EFFICACY, SAFETY AND TOLERABILITY OF SIMVASTATIN AND PRAVASTATIN FOR HYPERCHOLESTEROLEMIA
    DAUBRESSE, JC
    DEBACKER, G
    DUCOBU, J
    HARVENGT, C
    DEGENNES, JL
    DOUSTEBLAZY, P
    FARNIER, M
    ANDERS, G
    DAMMANN, HG
    NEUMANN, E
    SCHWARZE, B
    SEIFART, C
    KASTELEIN, J
    STALENHOEF, A
    KEIDAR, S
    CAPURSO, A
    DECESARIS, R
    DESCOVICH, G
    FELLIN, R
    FERUGLIO, F
    MALINI, P
    TRIMARCO, B
    SCOTT, R
    MARAIS, A
    KELLER, U
    MOCCETTI, T
    BLOOMFIELD, P
    CRAMB, R
    HUGHES, E
    SEED, M
    WRAY, R
    STEIN, E
    FRUCHART, J
    SWEANY, A
    SHAPIRO, D
    TATE, A
    AMERICAN JOURNAL OF CARDIOLOGY, 1993, 71 (16): : 1408 - 1414